Who
In numbers
- Trades disclosed
- 41
- Buys
- 7
- Sells
- 0
- Bought
- $565K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Oct 2009
- Last trade
- 18 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 22 Jun 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 27 Jun 2025filed 1 Jul 2025 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 6 Jun 2024filed 7 Jun 2024 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 15 Nov 2023filed 17 Nov 2023 | OMER OmerosBiotechnology | SEC FORM 4 Bought | $15K10,000 at $1.53 | filing |
| 23 Jun 2023filed 27 Jun 2023 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 21 Sep 2022filed 23 Sep 2022 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 17 Jun 2022filed 22 Jun 2022 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 11 Jun 2021filed 14 Feb 2022 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 22 Feb 2021filed 23 Feb 2021 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $27K5,000 at $5.30 | filing |
| 22 Feb 2021filed 23 Feb 2021 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $23K5,000 at $4.53 | filing |
| 22 Feb 2021filed 23 Feb 2021 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 22 Feb 2021filed 23 Feb 2021 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 5 Jun 2020filed 9 Jun 2020 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 14 Dec 2019filed 17 Dec 2019 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,334 at $0.00 | filing |
| 14 Dec 2019filed 17 Dec 2019 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $25K3,334 at $7.56 | filing |
| 7 Jun 2019filed 11 Jun 2019 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 15 Jun 2018filed 18 Jun 2018 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 16 Jun 2017filed 16 Jun 2017 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Jun 2016filed 10 Jun 2016 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
News
Omeros Stock Falls 12% After EMA Committee Reaffirms Negative Narsoplimab OpinionOMER · rttnews.com · 16 Oct 2026
0 headlines in the last 90 days name Peter A. Demopulos; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.